Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ON24 INC. Director's Dealing 2023

Jun 1, 2023

33490_dirs_2023-05-31_9fa84637-f833-4b3a-a524-31d4ab53f21e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ON24 INC. (ONTF)
CIK: 0001110611
Period of Report: 2023-05-31

Reporting Person: Vattuone Steven (N/A)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 180751.00 Direct
Common Stock 38622.00 Direct
Common Stock 90332.00 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Options (Right to buy) $13.33 2030-12-11 Common Stock (9018.00) 9018.00 Direct
Stock Options (Right to buy) $13.33 2030-12-11 Common Stock (90982.00) 90982.00 Direct
Stock Options (Right to buy) $2.10 2028-05-25 Common Stock (70548.00) 70548.00 Direct
Stock Options (Right to buy) $2.00 2029-12-01 Common Stock (69486.00) 69486.00 Direct
Stock Options (Right to buy) $1.23 2029-12-01 Common Stock (95671.00) 95671.00 Direct

Footnotes

F1: The Reporting Person is voluntarily restating his holdings in light of the $1.09 special dividend declared on May 8, 2023, payable on or about June 15, 2023, to stockholders of record as of the close of business on May 22, 2023. Pursuant to antidilution provisions, the previously awarded restricted stock units ("RSUs") with 156,000 shares outstanding were automatically adjusted to represent RSUs to acquire 180,751 shares, as reflected herein. There were no other changes to the RSUs.

F2: The RSUs will vest quarterly in 12 equal installments over a three-year period, with the first installment vesting on June 1, 2023, in each case subject to the Reporting Person's continued service through the applicable vesting date.

F3: Pursuant to antidilution provisions, the previously awarded RSUs with 33,334 shares outstanding were automatically adjusted to represent RSUs to acquire 38,622 shares, as reflected herein. There were no other changes to the RSUs.

F4: The RSUs will vest semi-annually in three equal installments with the first 1/3 vesting on February 20. 2023, in each case subject to the Reporting Person's continued service through the applicable vesting date.

F5: Pursuant to antidilution provisions, the previously awarded RSUs with 77,963 shares outstanding were automatically adjusted to represent RSUs to acquire 90,332 shares, as reflected herein. There were no other changes to the RSUs.

F6: The RSUs will vest in 16 equal installments over a four-year period, with the first installment vesting on February 20, 2022, in each case subject to the Reporting Person's continued service through the applicable vesting date.

F7: Pursuant to antidilution provisions, the exercise price of $14.42 per share of the previously awarded options were automatically adjusted
to $13.33 per share, as reflected herein. There were no other changes to the options.

F8: The options vested with respect to 1/48th of such shares on February 1, 2021, with 1/48th of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F9: Pursuant to antidilution provisions, the previously awarded options to acquire 60,963 shares for an exercise
price of $2.44 per share were automatically adjusted to represent options to acquire 70,548 shares for an exercise
price of $2.10 per share, as reflected herein. There were no other changes to the options.

F10: The options are fully vested and exercisable.

F11: Pursuant to antidilution provisions, the previously awarded options to acquire 60,000 shares for an exercise
price of $2.32 per share were automatically adjusted to represent options to acquire 69,486 shares for an exercise
price of $2.00 per share, as reflected herein. There were no other changes to the options.

F12: The options vested with respect to 1/48th of such shares on December 23, 2019, with 1/48th of such shares vesting thereafter at the end of each full month of continuous service until fully vested.

F13: Pursuant to antidilution provisions, the exercise price of $2.32 per share of the previously awarded options were automatically adjusted
to $1.23 per share, as reflected herein. There were no other changes to the options.